At a glance
- Originator Wyeth
- Class Antihypertensives; Heart failure therapies; Sulfonylureas
- Mechanism of Action Diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 19 Oct 2000 Profile reviewed but no significant changes made
- 19 May 1995 No-Development-Reported for Congestive heart failure in USA (PO)
- 19 May 1995 No-Development-Reported for Hypertension in USA (PO)